Skip to main content
Premium Trial:

Request an Annual Quote

Ambion Grants AcroMetrix License to Its Armored Technology

NEW YORK, May 9 (GenomeWeb News) - Ambion has granted AcroMetrix the right to manufacture products incorporating its Armored nucleic acid packaging technology and distribute then to in vitro diagnostic laboratories and manufacturers, the company said last week.

 

According to Ambion, the technology involves putting nucleic acids in bacteriophage coat proteins to protect and stabilize RNA and DNA.

 

Specific terms of the deal withwere not disclosed.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.